VERACYTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
VERACYTE, INC. (VCYT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $28.89 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-02-26
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $28.89M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $38.06M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $24.47M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $23.45M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-12-31 | $28.89M 10-K · filed 2026-02-26 |
| 2024-12-31 | $38.06M 10-K · filed 2026-02-26 |
| 2023-12-31 | $24.47M 10-K · filed 2025-02-28 |
| 2022-12-31 | $23.45M 10-K · filed 2024-02-29 |
| 2021-12-31 | $78.91M 10-K · filed 2023-03-01 |
| 2020-12-31 | $135.88M 10-K · filed 2022-02-28 |
| 2019-12-31 | $79.76M 10-K · filed 2021-02-22 |
| 2018-12-31 | $27.34M 10-K · filed 2020-02-25 |
| 2017-12-31 | $4.53M 10-K · filed 2019-02-25 |
| 2016-12-31 | $8.52M 10-K · filed 2018-02-27 |
| 2016-09-30 | $8.64M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $2.86M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $3.35M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $6.51M 10-K · filed 2017-03-01 |
| 2015-09-30 | $2.79M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $16.69M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $7.55M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $12.40M 10-K · filed 2016-03-14 |
| 2014-09-30 | $12.37M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $30.22M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $34.65M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $26.96M 10-K · filed 2015-03-25 |
| 2013-09-30 | $21.93M 10-Q · filed 2013-11-25 |
| 2012-12-31 | $4.31M 10-K · filed 2015-03-25 |
| 2011-12-31 | $1.22M 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |